V
31.80
1.55 (5.12%)
Penutupan Terdahulu | 30.25 |
Buka | 30.09 |
Jumlah Dagangan | 1,003,630 |
Purata Dagangan (3B) | 990,173 |
Modal Pasaran | 2,478,644,480 |
Harga / Pendapatan (P/E TTM) | 102.58 |
Harga / Pendapatan (P/E Ke hadapan) | 20.88 |
Harga / Jualan (P/S) | 4.78 |
Harga / Buku (P/B) | 1.83 |
Julat 52 Minggu | |
Tarikh Pendapatan | 5 May 2025 - 9 May 2025 |
Margin Keuntungan | 7.13% |
Margin Operasi (TTM) | 7.03% |
EPS Cair (TTM) | 0.420 |
Pertumbuhan Hasil Suku Tahunan (YOY) | 18.20% |
Jumlah Hutang/Ekuiti (D/E MRQ) | 4.23% |
Nisbah Semasa (MRQ) | 5.10 |
Aliran Tunai Operasi (OCF TTM) | 89.42 M |
Aliran Tunai Bebas Leveraj (LFCF TTM) | 76.93 M |
Pulangan Atas Aset (ROA TTM) | 1.94% |
Pulangan Atas Ekuiti (ROE TTM) | 2.86% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Diagnostics & Research (US) | Menurun | Menurun |
Diagnostics & Research (Global) | Menurun | Menurun | |
Stok | Veracyte, Inc. | Menurun | Menaik |
AISkor Stockmoo
-0.8
Konsensus Penganalisis | 2.0 |
Aktiviti Orang Dalam | -4.0 |
Volatiliti Harga | 2.0 |
Purata Bergerak Teknikal | 0.0 |
Osilator Teknikal | -4.0 |
Purata | -0.80 |
Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against diseases such as thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis. The firm's product portfolio consists of products such as Afirma analysis, Percepta, Envisia, and others. |
|
Sektor | Healthcare |
Industri | Diagnostics & Research |
Gaya Pelaburan | Small Growth |
% Dimiliki oleh Orang Dalam | 0.45% |
% Dimiliki oleh Institusi | 107.64% |
Julat 52 Minggu | ||
Julat Harga Sasaran | ||
Tinggi | 45.00 (Stephens & Co., 41.51%) | Beli |
45.00 (Craig-Hallum, 41.51%) | Beli | |
Median | 42.00 (32.08%) | |
Rendah | 37.00 (Guggenheim, 16.35%) | Beli |
Purata | 42.00 (32.08%) | |
Jumlah | 5 Beli | |
Harga Purata @ Panggilan | 31.59 |
Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
---|---|---|---|---|
Needham | 08 May 2025 | 41.00 (28.93%) | Beli | 31.21 |
UBS | 08 May 2025 | 42.00 (32.08%) | Beli | 31.21 |
Guggenheim | 09 Apr 2025 | 37.00 (16.35%) | Beli | 32.62 |
Stephens & Co. | 26 Mar 2025 | 45.00 (41.51%) | Beli | 31.05 |
Craig-Hallum | 20 Mar 2025 | 45.00 (41.51%) | Beli | 31.84 |
Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
---|---|---|---|---|
CHAMBERS REBECCA | - | 26.74 | -5,370 | -143,594 |
FEBBO PHILLIP G. | - | 26.74 | -2,955 | -79,017 |
LEITE JOHN | - | 27.02 | -5,709 | -154,204 |
MCGUIRE ANNIE | - | 26.74 | -3,505 | -93,724 |
STAPLEY MARC | - | 26.74 | -9,399 | -251,329 |
WYGANT JONATHAN | - | 26.74 | -1,848 | -49,416 |
Jumlah Keseluruhan Kuantiti Bersih | -28,786 | |||
Jumlah Keseluruhan Nilai Bersih ($) | -771,283 | |||
Purata Pembelian Keseluruhan ($) | - | |||
Purata Jualan Keseluruhan ($) | 26.82 |
Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
---|---|---|---|---|---|---|
LEITE JOHN | Pegawai | 04 Jun 2025 | Jual automatik (-) | 2,809 | 27.29 | 76,658 |
STAPLEY MARC | Pegawai | 02 Jun 2025 | Dibuang (-) | 9,399 | 26.74 | 251,329 |
FEBBO PHILLIP G. | Pegawai | 02 Jun 2025 | Dibuang (-) | 2,955 | 26.74 | 79,017 |
WYGANT JONATHAN | Pegawai | 02 Jun 2025 | Dibuang (-) | 1,848 | 26.74 | 49,416 |
LEITE JOHN | Pegawai | 02 Jun 2025 | Dibuang (-) | 2,900 | 26.74 | 77,546 |
CHAMBERS REBECCA | Pegawai | 02 Jun 2025 | Dibuang (-) | 5,370 | 26.74 | 143,594 |
MCGUIRE ANNIE | Pegawai | 02 Jun 2025 | Dibuang (-) | 3,505 | 26.74 | 93,724 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2025 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |